Baseline markers of inflammation and coagulation have been shown to be powerful predictors of adverse outcomes in patients with HIV infection. In a study of 5098 participants in a completed randomized, controlled trial there were 252 patients with a primary cardiovascular event over a median follow-up of 29 months. The risk of such an event was highest in those patients with the highest levels of IL-6, hsCRP and D-dimer. Disruption of vascular integrity by trauma and other tissue insults leads to inflammation and activation of the coagulation cascade. The serine protease thrombin links these 2 processes. The proinflammatory function of thrombin is mediated by activation of protease-activated receptor 1 (PAR-1). We found that peripheral blood effector memory CD4(+) and CD8(+) T lymphocytes expressed PAR-1 and that expression was increased in CD8(+) T cells from human immunodeficiency virus (HIV)-infected patients. Thrombin enhanced cytokine secretion in CD8(+) T cells from healthy controls and HIV-infected patients. In addition, thrombin induced chemokinesis, but not chemotaxis, of CD8(+) T cells, which led to structural changes, including cell polarization and formation of a structure rich in F-actin and phosphorylated ezrin-radexin-moesin proteins. These findings suggest that thrombin mediates cross-talk between the coagulation system and the adaptive immune system at sites of vascular injury through increased T-cell motility and production of proinflammatory cytokines. The susceptibility of macrophages to HIV-1 infection is modulated during monocyte differentiation. IL-27 is an anti-HIV cytokine that also modulates monocyte activation. IL-27 was found to promote monocyte differentiation into macrophages that are nonpermissive for HIV-1 infection. Although IL-27 treatment did not affect expression of macrophage differentiation markers or macrophage biological functions, it confered HIV resistance by down-regulating spectrin βnonerythrocyte 1 (SPTBN1), a required host factor for HIV-1 infection as well as inducing the expression of novel microRNAS.

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Zip Code
Gill, Amanda L; Green, Samantha A; Abdullah, Shahed et al. (2016) Programed death-1/programed death-ligand 1 expression in lymph nodes of HIV infected patients: results of a pilot safety study in rhesus macaques using anti-programed death-ligand 1 (Avelumab). AIDS 30:2487-2493
Revell, Andrew D; Wang, Dechao; Wood, Robin et al. (2016) An update to the HIV-TRePS system: the development and evaluation of new global and local computational models to predict HIV treatment outcomes, with or without a genotype. J Antimicrob Chemother :
Imamichi, Hiromi; Dewar, Robin L; Adelsberger, Joseph W et al. (2016) Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy. Proc Natl Acad Sci U S A 113:8783-8
Smiley, Stephen T; Singh, Anjali; Read, Sarah W et al. (2015) Progress toward curing HIV infections with hematopoietic stem cell transplantation. Clin Infect Dis 60:292-7
INSIGHT START Study Group; Lundgren, Jens D; Babiker, Abdel G et al. (2015) Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. N Engl J Med 373:795-807
Green, Samantha A; Smith, Mindy; Hasley, Rebecca B et al. (2015) Activated platelet-T-cell conjugates in peripheral blood of patients with HIV infection: coupling coagulation/inflammation and T cells. AIDS 29:1297-308
Conlon, Kevin C; Lugli, Enrico; Welles, Hugh C et al. (2015) Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer. J Clin Oncol 33:74-82
Revell, A D; Boyd, M A; Wang, D et al. (2014) A comparison of computational models with and without genotyping for prediction of response to second-line HIV therapy. HIV Med 15:442-8
Le Saout, Cecile; Hasley, Rebecca B; Imamichi, Hiromi et al. (2014) Chronic exposure to type-I IFN under lymphopenic conditions alters CD4 T cell homeostasis. PLoS Pathog 10:e1003976
Imamichi, Hiromi; Natarajan, Ven; Adelsberger, Joseph W et al. (2014) Lifespan of effector memory CD4+ T cells determined by replication-incompetent integrated HIV-1 provirus. AIDS 28:1091-9

Showing the most recent 10 out of 45 publications